Esophageal Stenosis in a Patient with Breast Cancer after Chemotherapy: A Case Report and Review of Literature

Introduction: Esophageal stenosis after chemotherapy in breast cancer patients is rare. It is important to distinguish esophageal stenosis from esophageal metastasis caused by breast cancer.Case presentation: We present the case of a 62-year-old woman who was diagnosed with breast cancer 4 months prior, had dysphagia and was referred to our department for further treatment after 2 cycles of chemotherapy. She suffered from severe mouth ulcers, painful swallowing and large areas of skin pigmentation with overlying scaliness after every chemotherapy session. Endoscopy revealed that the lumen of the lower esophagus was obviously narrow with ulceration above the stenosis. Histological results demonstrated inflammatory fibrinous necrosis and granulation tissue, with no clear neoplastic component. Conclusion: Short-term esophageal stenosis after chemotherapy may be caused by local mucosal injury, but malignant tumors need to be excluded.

[1]  Y. Ichinose,et al.  [Patient with Recurrent Breast Cancer Who Developed Radiation Esophagitis with Severe Esophageal Stenosis after Combined Bevacizumab and Paclitaxel Therapy-A Case Report]. , 2020, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  L. Yuanyuan,et al.  Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china , 2020, Cost Effectiveness and Resource Allocation.

[3]  Yunsheng Yang,et al.  Review of esophageal metastasis from breast cancer. , 2020, Gland surgery.

[4]  M. Sanaka,et al.  Metastatic Breast Cancer Presenting as Esophageal Stricture. , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  Wanqing Chen,et al.  Breast cancer in China. , 2014, The Lancet. Oncology.

[6]  F. Kousar,et al.  Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer. , 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[7]  N. Brünner,et al.  Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[8]  Philip R. Cohen Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer. , 2009, Journal of drugs in dermatology : JDD.